{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:40Z","timestamp":1791196840779,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13181-019-00749-4","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T15:04:49Z","timestamp":1575990289000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity"],"prefix":"10.1007","volume":"16","author":[{"name":"on behalf of the Toxicology Investigators Consortium\u00a0(ToxIC)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7950-6762","authenticated-orcid":false,"given":"Brian","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Dunkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim P.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Rianprakaisang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed S.","family":"Alsukaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane P.","family":"Calello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Kazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"5","key":"749_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/ADM.0000000000000249","volume":"10","author":"GL Stassinos","year":"2016","unstructured":"Stassinos GL, Klein-Schwartz W. Bupropion \u201cabuse\u201d reported to US poison centers. J Addict Med. 2016;10(5):357\u201362. https:\/\/doi.org\/10.1097\/ADM.0000000000000249.","journal-title":"J Addict Med"},{"issue":"9","key":"749_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","volume":"6","author":"KF Foley","year":"2006","unstructured":"Foley KF, DeSanty KP, Kast RE. Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006;6(9):1249\u201365. https:\/\/doi.org\/10.1586\/14737175.6.9.1249.","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"749_CR3","first-page":"256","volume":"50","author":"J Davidson","year":"1989","unstructured":"Davidson J. Seizures and bupropion: a review. J Clin Psychiatry. 1989;50(7):256\u201361.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"749_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0735-6757(94)90195-3","volume":"12","author":"HA Spiller","year":"1994","unstructured":"Spiller HA, Ramoska EA, Krenzelok EP, Sheen SR, Borys DJ, Villalobos D, et al. Bupropion overdose: a 3-year multi-center retrospective analysis. Am J Emerg Med. 1994;12(1):43\u20135.","journal-title":"Am J Emerg Med"},{"key":"749_CR5","doi-asserted-by":"crossref","unstructured":"Reaume M, Parmar M, Tanase A, Rosenblatt R. A fatal case of bupropion-induced cardiotoxicity refractory to impella placement. C41. CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. Am Thoracic Soc; 2019. p. A4817-A.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A4817"},{"issue":"5","key":"749_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1472-8206.2011.00953.x","volume":"26","author":"B Caillier","year":"2012","unstructured":"Caillier B, Pilote S, Castonguay A, Patoine D, Menard-Desrosiers V, Vigneault P, et al. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundam Clin Pharmacol. 2012;26(5):599\u2013608. https:\/\/doi.org\/10.1111\/j.1472-8206.2011.00953.x.","journal-title":"Fundam Clin Pharmacol"},{"key":"749_CR7","doi-asserted-by":"crossref","unstructured":"Xiang XM, Phillips DJ. Nonepileptic myoclonus following bupropion overdose. Clin Pediatr (Phila) 2017:9922817737082.","DOI":"10.1177\/0009922817737082"},{"issue":"1","key":"749_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ddr.430010103","volume":"1","author":"R Ferris","year":"1981","unstructured":"Ferris R, White H, Cooper B, Maxwell R, Tang F, Beaman O, et al. Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin\u2122). Drug Dev Res. 1981;1(1):21\u201335.","journal-title":"Drug Dev Res"},{"issue":"2","key":"749_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/npp.1994.43","volume":"11","author":"BR Cooper","year":"1994","unstructured":"Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology. 1994;11(2):133\u201341.","journal-title":"Neuropsychopharmacology."},{"issue":"6","key":"749_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuropharm.2005.05.004","volume":"49","author":"KS Rau","year":"2005","unstructured":"Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, et al. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 2005;49(6):820\u201330. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.05.004.","journal-title":"Neuropharmacology."},{"issue":"1","key":"749_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s002130000665","volume":"155","author":"J Dong","year":"2001","unstructured":"Dong J, Blier P. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology. 2001;155(1):52\u20137.","journal-title":"Psychopharmacology"},{"issue":"7","key":"749_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.neuropharm.2008.07.028","volume":"55","author":"M El Mansari","year":"2008","unstructured":"El Mansari M, Ghanbari R, Janssen S, Blier P. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology. 2008;55(7):1191\u20138.","journal-title":"Neuropharmacology."},{"issue":"1","key":"749_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-011-2260-1","volume":"217","author":"R Ghanbari","year":"2011","unstructured":"Ghanbari R, El Mansari M, Blier P. Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology. 2011;217(1):61\u201373.","journal-title":"Psychopharmacology"},{"issue":"10","key":"749_CR14","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/sj.npp.1300489","volume":"29","author":"N Haddjeri","year":"2004","unstructured":"Haddjeri N, Lavoie N, Blier P. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology. 2004;29(10):1800\u20136. https:\/\/doi.org\/10.1038\/sj.npp.1300489.","journal-title":"Neuropsychopharmacology."},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681\u201398. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105140.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"749_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s13181-010-0021-x","volume":"6","author":"EL Thorpe","year":"2010","unstructured":"Thorpe EL, Pizon AF, Lynch MJ, Boyer J. Bupropion induced serotonin syndrome: a case report. J Med Toxicol. 2010;6(2):168\u201371. https:\/\/doi.org\/10.1007\/s13181-010-0021-x.","journal-title":"J Med Toxicol"},{"issue":"2","key":"749_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13181-010-0084-8","volume":"6","author":"PK Gillman","year":"2010","unstructured":"Gillman PK. Bupropion, bayesian logic and serotonin toxicity. J Med Toxicol. 2010;6(2):276\u20137. https:\/\/doi.org\/10.1007\/s13181-010-0084-8.","journal-title":"J Med Toxicol"},{"issue":"4","key":"749_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13181-011-0177-z","volume":"7","author":"PM Wax","year":"2011","unstructured":"Wax PM, Kleinschmidt KC, Brent J, Investigators ATCR. The toxicology investigators consortium (ToxIC) registry. J Med Toxicol. 2011;7(4):259\u201365. https:\/\/doi.org\/10.1007\/s13181-011-0177-z.","journal-title":"J Med Toxicol"},{"issue":"3","key":"749_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13181-018-0679-z","volume":"14","author":"LA Farrugia","year":"2018","unstructured":"Farrugia LA, Rhyee SH, Campleman SL, Judge B, Kao L, Pizon A, et al. The toxicology investigators consortium case registry-the 2017 annual report. J Med Toxicol. 2018;14(3):182\u2013211. https:\/\/doi.org\/10.1007\/s13181-018-0679-z.","journal-title":"J Med Toxicol"},{"issue":"13","key":"749_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1503\/cmaj.131534","volume":"186","author":"N Stall","year":"2014","unstructured":"Stall N, Godwin J, Juurlink D. Bupropion abuse and overdose. Can Med Assoc J. 2014;186(13):1015.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"749_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jemermed.2004.02.017","volume":"27","author":"G Shepherd","year":"2004","unstructured":"Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27(2):147\u201351. https:\/\/doi.org\/10.1016\/j.jemermed.2004.02.017.","journal-title":"J Emerg Med"},{"key":"749_CR22","unstructured":"American Association of Poison Control Centers. National Poison Data System (NPDS) NPDS Coding Users\u2019 Manual\u00a92014."},{"issue":"11","key":"749_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0028-3908(83)90198-3","volume":"22","author":"RM Ferris","year":"1983","unstructured":"Ferris RM, Beaman OJ. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain. Neuropharmacology. 1983;22(11):1257\u201367.","journal-title":"Neuropharmacology."},{"issue":"5","key":"749_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.wnf.0000142754.46045.8c","volume":"27","author":"RP Munhoz","year":"2004","unstructured":"Munhoz RP. Serotonin syndrome induced by a combination of bupropion and SSRIs. Clin Neuropharmacol. 2004;27(5):219\u201322.","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"749_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jclinane.2011.04.017","volume":"24","author":"S Gollapudy","year":"2012","unstructured":"Gollapudy S, Kumar V, Dhamee MS. A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. J Clin Anesth. 2012;24(3):251\u20132. https:\/\/doi.org\/10.1016\/j.jclinane.2011.04.017.","journal-title":"J Clin Anesth"},{"issue":"9","key":"749_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","volume":"96","author":"EJ Dunkley","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635\u201342.","journal-title":"QJM."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00749-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00749-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00749-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T02:06:30Z","timestamp":1607479590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00749-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00749-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of the US Air Force Office of the Surgeon General, the Department of the Air Force, the Department of Defense, or the US Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}